EuroLeague License Decisions Delayed, Affecting Israeli Clubs
Translated & summarized from Mako by baba
The EuroLeague postponed a decision on new team licenses, leaving Israeli clubs Hapoel Jerusalem and Hapoel Tel Aviv in limbo regarding their participation. Thirteen teams are competing for eight available franchise licenses, with a further meeting scheduled. The EuroLeague was officially approved to expand to 24 teams by the 2027/28 season.
The story in 5 lines · by baba
- EuroLeague license decisions were delayed, impacting Hapoel Jerusalem and Hapoel Tel Aviv.
- Thirteen teams are competing for eight new franchise licenses in the EuroLeague.
- Hapoel Jerusalem and Hapoel Tel Aviv are among the clubs seeking licenses.
- The EuroLeague will officially expand to 24 teams starting in the 2027/28 season.
- A further meeting will be held soon to continue discussions on the licenses.
The EuroLeague management held a meeting on Tuesday regarding the distribution of new licenses but postponed a final decision, leaving Hapoel Jerusalem and Hapoel Tel Aviv uncertain about their future in Europe's top basketball competition. The league's owners did not finalize which teams will receive the coveted new licenses, with another meeting expected soon to continue discussions. Currently, 13 clubs are vying for eight franchise licenses. Among the contenders are Hapoel Tel Aviv and Hapoel Jerusalem, alongside Partizan, Crvena Zvezda, Dubai, Valencia, Virtus Bologna, Paris, PAOK, Aris, Napoli, Roma, and London Lions. In parallel, the EuroLeague's expansion to 24 teams was officially approved, meaning the competition will include four additional clubs starting from the 2027/28 season. The ongoing delay means the competition for the eight licenses will continue.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 2Right 1Other 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
